Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Dr. Lloyd S. Miller Appointed Chief Medical Officer of Ailux
13/10/2026
On October 13, according to XtalPi, Ailux, a biotechnology company founded and controlled by XtalPi, announced the appointment of Dr. Lloyd S. Miller as Chief Medical Officer.
Latest
4 m ago
Tencent Holdings (00700.HK) plans to issue 10-year and 20-year US dollar bonds, with initial guidance in the T+115bps area and the T+140bps area.
5 m ago
Tencent Holdings (00700.HK) plans to issue 10-year and 30-year RMB bonds, with initial guidance in the 2.90% area and 3.50% area.
5 m ago
The Taiwan dollar fell to 32.016 against the US dollar, the lowest level since mid-August.
6 m ago
HK Stock Movement | Kingdee International (00268.HK) Rises Over 6%; AI-Native Product Contract Signings in First Three Quarters Exceed RMB 1 Billion; Secures Contracts with Multiple Well-Known Enterprises
6 m ago
[Star Device Fusion Enterprise "YanChao Fusion" Completes Several Hundred Million Yuan Pre-A Round Financing] On October 13, YanChao Fusion announced that the company completed a Pre-A round financing of several hundred million yuan in the third quarter, jointly invested by industrial and financial investment institutions including Yanshan Technology, Hongyuan Investment Group, Wanlian Guangsheng, and Hongshan Capital. It is reported that YanChao Fusion currently has a full-time team of nearly 60 people and nearly 10 senior consultant experts, covering fields such as fusion physics, device engineering, superconducting magnets, and superconducting applications. The company plans to build three generations of stellarator devices YF-1/2/3. YanChao Fusion stated that the company is committed to the commercialization of stellarator fusion power generation, and in the short to medium term can generate revenue by applying its core superconducting technology to the energy, industrial, medical, and aerospace sectors.
See all latest